Zomedica (ZOM)
(Delayed Data from AMEX)
$0.13 USD
0.00 (2.23%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $0.13 0.00 (-2.26%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Zomedica Corp. [ZOM]
Reports for Purchase
Showing records 21 - 33 ( 33 total )
Company: Zomedica Corp.
Industry: Medical - Drugs
Company: Zomedica Corp.
Industry: Medical - Drugs
Company: Zomedica Corp.
Industry: Medical - Drugs
Miller Agreement Strengthens Commercial Machinery of the Upcoming TRUFORMA Launch; Higher $1.20 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Zomedica Corp.
Industry: Medical - Drugs
Razor-Sharp Focus on TRUFORMA Launch in 1Q21; Lower $0.30PT on Dilution; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Zomedica Corp.
Industry: Medical - Drugs
New Guard Takes Charge of the Strengthened Company; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Zomedica Corp.
Industry: Medical - Drugs
TRUFORMA Development Update; Financial Overhang Removed; Lower PT to $0.50; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Zomedica Corp.
Industry: Medical - Drugs
TRUFORMA Launch Expected in 1Q20 With Two Assays; Lower PT $0.65; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Zomedica Corp.
Industry: Medical - Drugs
Two Product Launches Expected in 2020; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Zomedica Corp.
Industry: Medical - Drugs
Unique Animal Health Company With a Diversified Pipeline; Initiate With Buy and $1.00 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Zomedica Corp.
Industry: Medical - Drugs
We are updating our price target to USD $3.54 / CAD $4.60
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A